| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Sofinnova Venture Partners X, L.P. last filed a Form 4 in February 2023, as 10% Owner at JBIO. The filings on record cover 3 companies.
Our model assigns Sofinnova Venture Partners X, L.P. a middling insider score of 55/100, based on 4 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +14.9%.
At the last filing, the largest reported position was 3,467,156 shares of VERA. Net of sales, the VERA filings show accumulation of 1,279,652 shares.
Sofinnova Venture Partners X, L.P. has 5 Form 4 filings on record from February 2021 to February 2023, across 3 companies: 10% Owner at Vera Therapeutics (VERA), 2021–2023; 10% Owner at Jade Biosciences (JBIO), 2021; 10% Owner at Bolt Biotherapeutics (BOLT), 2021.
The 9 reported transactions were 5 open-market purchases and 4 conversions.
Counted by filing, the open-market trades come to 5 purchases worth about $28.0M and no sales.
The largest open-market purchase was 450,000 shares of BOLT at an average $20.00 on February 9, 2021, about $9.0M.
Shares as reported in the last Form 4 for each company; the most recent is from February 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2023 | VERA Vera Therapeutics, Inc. | 10% Owner | Buy | 285,714 | $7.00 | $1,999,998.00 | +9.0% | +8.5% | +445.9% | |
| Feb 10, 2022 | VERA Vera Therapeutics, Inc. | 10% Owner | Buy | 266,666 | $15.00 | $3,999,990.00 | +9.1% | -14.9% | -58.0% | |
| Jul 2, 2021 | JBIO Jade Biosciences, Inc. | 10% Owner | Buy | 357,142 | $14.00 | $4,999,988.00 | +10.5% | +5.2% | -15.1% | |
| May 18, 2021 | VERA Vera Therapeutics, Inc. | 10% Owner | Buy | 727,272 | $11.00 | $7,999,992.00 | +33.2% | +37.7% | +32.9% | |
| Feb 9, 2021 | BOLT Bolt Biotherapeutics, Inc. | 10% Owner | Buy | 450,000 | $20.00 | $9,000,000.00 | +19.5% | - | - |